Sameh Hamdy Abdelmageed Soror

Title: Sameh Hamdy Abdelmageed Soror: Innovator in Hepatitis C Research

Introduction

Sameh Hamdy Abdelmageed Soror is a notable inventor based in Jeddah, Saudi Arabia. He has made significant contributions to the field of medical research, particularly in the development of compounds aimed at combating hepatitis C virus (HCV) infections. With a total of 2 patents, his work showcases the potential of innovative pharmaceutical solutions.

Latest Patents

Soror's latest patents include "Imidazole-based compounds as hepatitis C virus inhibitors." These compounds feature an imidazole core that is disubstituted via amide links. The patents also describe a pharmaceutical composition that incorporates the imidazole-based compound, a method for preparing these compounds, and a method for utilizing the pharmaceutical composition in the treatment of HCV infection. Another significant patent is "Compounds for inhibiting NS3 and compositions containing the inhibited protein," which further emphasizes the role of imidazole-based compounds in HCV treatment.

Career Highlights

Soror is affiliated with King Abdulaziz University, where he conducts his research and development activities. His work is pivotal in advancing the understanding and treatment of hepatitis C, a virus that affects millions worldwide. His innovative approach to drug development has the potential to improve patient outcomes significantly.

Collaborations

Some of his notable coworkers include Moustafa Elsayed El-Araby and Abdelsattar Mansour Omar. Their collaborative efforts contribute to the advancement of research in the field of hepatitis C and related medical innovations.

Conclusion

Sameh Hamdy Abdelmageed Soror's contributions to hepatitis C research through his innovative patents highlight the importance of continued research and development in the medical field. His work not only advances scientific knowledge but also offers hope for effective treatments for those affected by HCV.